Wells Fargo raised the firm’s price target on Danaher (DHR) to $230 from $205 and keeps an Equal Weight rating on the shares. The firm notes the company reaffirmed its 2025 EPS guide, despite lowering Q4 organic growth. Initial 2026 outlook calls for positive high single digit EPS growth, even at low-end of +3%-6% core revenue growth, which seems to leave room for upside on Life Sci, OP margin and capital allocation fronts.
Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on DHR:
